Ala alleviated cardiomyocyte hypertrophy, cardiac fibrosis, and artery remodeling via inhibiting the PKA [9], Akt [33], and p38MAPK [34] signaling pathways, respectively. The gene discussed is AKT1; the disease is fibrosis.